WO2019098810A3 - 신규 유산균 및 이의 용도 - Google Patents

신규 유산균 및 이의 용도 Download PDF

Info

Publication number
WO2019098810A3
WO2019098810A3 PCT/KR2018/014271 KR2018014271W WO2019098810A3 WO 2019098810 A3 WO2019098810 A3 WO 2019098810A3 KR 2018014271 W KR2018014271 W KR 2018014271W WO 2019098810 A3 WO2019098810 A3 WO 2019098810A3
Authority
WO
WIPO (PCT)
Prior art keywords
lactic acid
acid bacteria
novel lactic
inhibition
preventing
Prior art date
Application number
PCT/KR2018/014271
Other languages
English (en)
French (fr)
Other versions
WO2019098810A2 (ko
Inventor
김동현
한명주
Original Assignee
경희대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180142811A external-priority patent/KR102250597B1/ko
Priority to RU2020116733A priority Critical patent/RU2778773C2/ru
Priority to CN201880075208.6A priority patent/CN111655839B/zh
Priority to US16/765,834 priority patent/US11324786B2/en
Priority to JP2020527989A priority patent/JP7242668B2/ja
Priority to AU2018368258A priority patent/AU2018368258B2/en
Application filed by 경희대학교 산학협력단 filed Critical 경희대학교 산학협력단
Priority to EP24162214.1A priority patent/EP4364745A2/en
Priority to CA3083094A priority patent/CA3083094A1/en
Priority to EP18878662.8A priority patent/EP3715449B1/en
Publication of WO2019098810A2 publication Critical patent/WO2019098810A2/ko
Publication of WO2019098810A3 publication Critical patent/WO2019098810A3/ko
Priority to US17/714,955 priority patent/US11963988B2/en
Priority to JP2023031186A priority patent/JP2023071848A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

본 발명은 신규한 유산균인 락토바실러스 뮤코세 및 비피도박테리움 롱검에 관한 것으로, 구체적으로 노화인자인 p16 단백질 발현 및 염증성 인자를 억제함으로써 기억 장애, 학습 장애 또는 정신 장애의 예방 및 치료, 염증성 질환의 예방 및 치료에 유용한 신규한 유산균을 포함하는 조성물에 관한 것이다.
PCT/KR2018/014271 2017-11-20 2018-11-20 신규 유산균 및 이의 용도 WO2019098810A2 (ko)

Priority Applications (10)

Application Number Priority Date Filing Date Title
EP18878662.8A EP3715449B1 (en) 2017-11-20 2018-11-20 Novel lactic acid bacteria and use thereof
CN201880075208.6A CN111655839B (zh) 2017-11-20 2018-11-20 新型乳酸菌及其用途
US16/765,834 US11324786B2 (en) 2017-11-20 2018-11-20 Lactic acid bacteria and use thereof
JP2020527989A JP7242668B2 (ja) 2017-11-20 2018-11-20 新規乳酸菌及びその用途
AU2018368258A AU2018368258B2 (en) 2017-11-20 2018-11-20 Novel lactic acid bacteria and use thereof
RU2020116733A RU2778773C2 (ru) 2017-11-20 2018-11-20 Новые молочнокислые бактерии и их применение
EP24162214.1A EP4364745A2 (en) 2017-11-20 2018-11-20 Novel lactic acid bacteria and use thereof
CA3083094A CA3083094A1 (en) 2017-11-20 2018-11-20 Novel lactic acid bacteria and use thereof
US17/714,955 US11963988B2 (en) 2017-11-20 2022-04-06 Lactic acid bacteria and use thereof
JP2023031186A JP2023071848A (ja) 2017-11-20 2023-03-01 新規乳酸菌及びその用途

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20170155078 2017-11-20
KR10-2017-0155078 2017-11-20
KR1020180142811A KR102250597B1 (ko) 2017-11-20 2018-11-19 신규 유산균 및 이의 용도
KR10-2018-0142811 2018-11-19

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US16/765,834 A-371-Of-International US11324786B2 (en) 2017-11-20 2018-11-20 Lactic acid bacteria and use thereof
US17/714,955 Continuation US11963988B2 (en) 2017-11-20 2022-04-06 Lactic acid bacteria and use thereof

Publications (2)

Publication Number Publication Date
WO2019098810A2 WO2019098810A2 (ko) 2019-05-23
WO2019098810A3 true WO2019098810A3 (ko) 2019-07-18

Family

ID=66537813

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/014271 WO2019098810A2 (ko) 2017-11-20 2018-11-20 신규 유산균 및 이의 용도

Country Status (1)

Country Link
WO (1) WO2019098810A2 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7438709B2 (ja) * 2019-10-02 2024-02-27 日清食品ホールディングス株式会社 認知機能を改善するビフィズス菌
CN112877231B (zh) * 2019-11-29 2023-06-23 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 具有抑菌和抗氧化活性的乳酸菌及其应用
CN111826322A (zh) * 2020-08-03 2020-10-27 江西善行生物科技有限公司 一种长双歧杆菌及其在抗衰老中的应用
CN113122473B (zh) * 2021-04-10 2022-08-02 江南大学 增强记忆能力的乳酸杆菌bb1及其应用
CN114098084A (zh) * 2021-04-13 2022-03-01 中国人民解放军军事科学院军事医学研究院 一种缓解长期低剂量辐射暴露所致认知损伤的益生菌组合物及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009100692A (ja) * 2007-10-24 2009-05-14 Crossfield Bio Inc 新規なラクトバチルス属微生物および哺乳動物用乳酸菌製剤
WO2010060722A1 (en) * 2008-11-03 2010-06-03 Nestec S.A. A nutritional composition comprising probiotics and improving sleep patterns
JP2015077133A (ja) * 2008-04-15 2015-04-23 ネステク ソシエテ アノニム ビフィドバクテリウム・ロンガム及び海馬ｂｄｎｆ発現
WO2017134240A1 (en) * 2016-02-04 2017-08-10 Universiteit Gent Use of microbial communities for human and animal health

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101946818B1 (ko) 2015-03-12 2019-02-13 주식회사 파미니티 기억력 개선, 인지기능장애 및 뇌질환의 예방, 개선 또는 치료용 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009100692A (ja) * 2007-10-24 2009-05-14 Crossfield Bio Inc 新規なラクトバチルス属微生物および哺乳動物用乳酸菌製剤
JP2015077133A (ja) * 2008-04-15 2015-04-23 ネステク ソシエテ アノニム ビフィドバクテリウム・ロンガム及び海馬ｂｄｎｆ発現
WO2010060722A1 (en) * 2008-11-03 2010-06-03 Nestec S.A. A nutritional composition comprising probiotics and improving sleep patterns
WO2017134240A1 (en) * 2016-02-04 2017-08-10 Universiteit Gent Use of microbial communities for human and animal health

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DI CERBO, A. ET AL.: "Mechanisms and therapeutic effectiveness of lactobacilli", JOURNAL OF CLINICAL PATHOLOGY, vol. 69, no. 3, 2016, pages 187 - 203, XP055390904, doi:10.1136/jclinpath-2015-202976 *
See also references of EP3715449A4 *

Also Published As

Publication number Publication date
WO2019098810A2 (ko) 2019-05-23

Similar Documents

Publication Publication Date Title
WO2019098810A3 (ko) 신규 유산균 및 이의 용도
EP4257194A3 (en) Use of microbial communities for human and animal health
MX2020007987A (es) Cepa lactobacillus plantarum kbl396 y uso de la misma.
BR112018005195A2 (ko) New lactic acid bacteria having various functions and uses thereof
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
MX2020003198A (es) Bacterias acidolácticas novedosas y uso de las mismas.
EP3584308A3 (en) Compositions and methods
WO2019118515A3 (en) Compositions and methods for suppressing pathogenic organisms
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
IL291460A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
MY197900A (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
PL3979982T3 (pl) Kompozycja zawierająca bakteryjny szczep lactobacillus paracasei i kwas hialuronowy oraz jej zastosowanie do leczenia skóry
CN107208107A8 (zh) 伤口愈合的方法
ATE421256T1 (de) Probiotische zusammensetzung
BR112019001116A2 (pt) composição probiótica usada no tratamento e/ou prevenção da dermatite atópica
WO2005112976A3 (en) Probiotic compounds from lactobacillus gg and uses therefor
EP4012019A4 (en) BIFIDOBACTERIUM BREVE 207-1 AND ITS USE
MX2017016283A (es) Lactobacillus paracasei para la produccion de acido linoleico conjugado, preparaciones nutricionales y farmaceuticas que lo contienen y sus usos.
IL291445A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
ZA201804863B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
EP3715449A4 (en) NEW LACTIC BACTERIA AND THEIR USE
WO2017199022A3 (en) Lactobacillus rhamnosus lysate compositions and uses thereof
EP3875576A4 (en) NEW LACTIC BACTERIA AND THEIR USE
MX2021003224A (es) Combinacion de probioticos para el tratamiento de trastornos gastrointestinales relacionados con la inflamacion.
WO2021004958A3 (en) Compositions comprising bacterial strains

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 3083094

Country of ref document: CA

Ref document number: 2020527989

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2020116733

Country of ref document: RU

ENP Entry into the national phase

Ref document number: 2018368258

Country of ref document: AU

Date of ref document: 20181120

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2018878662

Country of ref document: EP

Effective date: 20200622

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18878662

Country of ref document: EP

Kind code of ref document: A2